Review: When should bariatric surgery be used in the treatment of type 2 diabetes?

Jonathan Pinkney*, David Kerrigan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

<jats:p> Non-randomised observational studies show that bariatric surgery has a highly beneficial impact on diabetes. Bariatric surgery leads to remission of bariatric surgery has a highly beneficial impact on Diabetes. Bariatric surgery leads to remission of diabetes in at least two thirds of patients, and reductions in drug therapy for many others. Those with more recent onset diabetes, fewer treatment requirements, and able to achieve most weight loss are more likely to achieve remission. Therefore, bariatric surgery is an attractive treatment option to consider for selected more severely obese patients with favourable characteristics. Although data on bariatric surgery in subjects with diabetes are provocative, all recent clinical studies have been uncontrolled or otherwise flawed. Moreover, bariatric surgery has yet to be compared either with medical treatment for weight loss, or against standard medical treatment for diabetes in any randomised controlled trial with diabetes-specific end points. There remains a need for long-term randomised controlled trials before bariatric surgery is used more widely as a first-line treatment for obese patients with type 2 diabetes. </jats:p>
Original languageEnglish
Pages (from-to)232-237
Number of pages0
JournalThe British Journal of Diabetes &amp; Vascular Disease
Volume4
Issue number4
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Dive into the research topics of 'Review: When should bariatric surgery be used in the treatment of type 2 diabetes?'. Together they form a unique fingerprint.

Cite this